759
Views
11
CrossRef citations to date
0
Altmetric
Drug Profile

Subcutaneous and intravenous belimumab in the treatment of systemic lupus erythematosus: a review of data on subcutaneous and intravenous administration

, &
Pages 925-938 | Received 05 Jul 2017, Accepted 22 Aug 2017, Published online: 12 Sep 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Íñigo Rua-Figueroa Fernández de Larrinoa, María J Cuadrado Lozano, Carlos Marras Fernández-Cid, Tatiana Cobo Ibáñez, Tarek C Salman Monte, Mercedes Freire González, Francisco J Hidalgo Bermejo, Carmen San Román Gutiérrez & Josefina Cortés-Hernández. (2022) Preventing organ damage in systemic lupus erythematosus: the impact of early biological treatment. Expert Opinion on Biological Therapy 22:7, pages 821-829.
Read now
Juan M. Mejía-Vilet & Juanita Romero-Díaz. (2021) Voclosporin: a novel calcineurin inhibitor for the management of lupus nephritis. Expert Review of Clinical Immunology 17:9, pages 937-945.
Read now
Hamdy MA Ahmed, Samar Abohamad, Mohanad Elfishawi, Mohamed Tharwat Hegazy & Kadambari Vijaykumar. (2018) Subcutaneous formulation of belimumab in treatment of systemic lupus erythematosus: a critical review with focus on safety and satisfaction. Patient Preference and Adherence 12, pages 2475-2479.
Read now

Articles from other publishers (8)

Clémence Marin, Gaëlle Noé, Dimitri Schlemmer, Quentin Beaulieu, Pascal Robidou, Bochra Mansour, Christophe Hirtz, Jérôme Vialaret, Marie Antignac, Quentin Moyon, Neila Benameur, Zahir Amoura & Noël Zahr. (2023) Determination of plasma concentration of Belimumab by LC-MS/MS: method development, validation, and clinical application. Journal of Pharmaceutical and Biomedical Analysis, pages 115730.
Crossref
Panagiotis Athanassiou & Lambros Athanassiou. (2023) Current Treatment Approach, Emerging Therapies and New Horizons in Systemic Lupus Erythematosus. Life 13:7, pages 1496.
Crossref
O.B. Iaremenko & D.I. Koliadenko. (2022) Clinical and laboratory characteristics of patients with articular manifestations of systemic lupus erythematosus. PAIN, JOINTS, SPINE 12:3, pages 108-113.
Crossref
E. L. Nasonov, S. K. Soloviev & A. V. Arshinov. (2022) Systemic lupus erythematosus: history and modernity. Rheumatology Science and Practice 60:4, pages 397-412.
Crossref
E. L. Nasonov, T. V. Popkova & A. M. Lila. (2021) Belimumab in the treatment of systemic lupus erythematosus: 20 years of basic research, 10 years of clinical practice. Rheumatology Science and Practice 59:4, pages 367-383.
Crossref
Panagiotis Athanassiou, Lambros Athanassiou & Ifigenia Kostoglou-Athanassiou. 2021. Lupus - Need to Know. Lupus - Need to Know.
Beatriz Frade-Sosa, Juan C. Sarmiento-Monroy, Tarek C. Salman-Monte, Patricia Corzo & José A. Gómez-Puerta. (2021) Diagnosis and treatment of articular manifestations of systemic lupus erythematosus. Revista Colombiana de Reumatología 28, pages 90-100.
Crossref
Danielle H. Wang & Daniel J. Wallace. (2020) New Insights Into Systemic Lupus Erythematosus Therapies. JCR: Journal of Clinical Rheumatology Publish Ahead of Print.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.